SCHEMBL7141827

SCHEMBL7141827

CC(C(=O)O)C1C2(C)CCCC1(C)CN(C)C2

nearest known ligand 0.40

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.40
NFKB1 P19838 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8315891 0.70 CYP2C19 (0.33) TSHRNFKB1CYP2C19
SCHEMBL6747801 0.64
SCHEMBL21457842 0.59 NR3C1 (0.40) TSHRNFKB1CYP2C19
SCHEMBL14826670 0.58 SMN1; SMN2 (0.52) TSHR
SCHEMBL21457838 0.58 NR3C1 (0.40)
SCHEMBL27628591 0.58 ALDH1A1 (0.37)
SCHEMBL20572985 0.58 SLC1A2 (0.36) TSHR
SCHEMBL27961792 0.58 TSHR (0.57) TSHRNFKB1CYP2C19
SCHEMBL18952262 0.58 TSHR (0.42) TSHRNFKB1CYP2C19
SCHEMBL18220604 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6518423-B1 These compounds are useful as drugs efficacious in the prevention and treatment of these various inflammatory diseases and immunologic diseases, such as rheumatoid arthritis, atopic dermatitis, psoriasis, asthma, and EISAI CO., LTD. (JP) 2003-02-11 US disclosed